| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 [R. Z., N. B., J. D. G.], and Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [D. B. L.]
In vivo 31P magnetic resonance spectroscopy
demonstrates that human melanoma xenografts can be significantly
acidified by induction of hyperglycemia combined with administration of
m-iodobenzylguanidine (MIBG), an inhibitor of
mitochondrial respiration. In melanoma xenografts (
8 mm diameter),
intracellular pH (pHi, measured by the chemical shift of
the Pi resonance) and extracellular pH (pHe,
measured with 3-aminopropylphosphonate) was reduced by less than 0.2
unit during i.v. infusion of glucose for 40 min. Administration of MIBG
(30 mg/kg) under hyperglycemic conditions (26 mM) reduced
tumor pHi and pHe by
0.4
(P < 0.001) and
0.6
(P < 0.001) unit, respectively;
coincidentally, the nucleoside triphosphates:Pi ratio
decreased
60% (P < 0.004) relative
to the baseline level. Minimal changes in pHi and
pHe and a small decrease in nucleoside
triphosphates:Pi ratio (26%, P = 0.2) were observed in liver in response to MIBG plus
hyperglycemia. These results suggest that under normoglycemic and
hyperglycemic conditions, small human melanoma xenografts (
8 mm) may
exhibit a relatively high level of oxidative phosphorylation that may
be blocked by MIBG. The acidification may result from increased lactate
production as a direct effect of MIBG inhibition of respiration in
mitochondria of tumor cells, or through indirect systemic effects,
which remain to be identified. The synergetic effects of MIBG and
hyperglycemia result in significant acidification of the tumor and a
decrease in tumor bioenergetic status, and the effects are largely
selective for tumors in comparison with normal tissues.
This article has been cited by other articles:
![]() |
Y. Shimoyama, Y. Akihara, D. Kirat, H. Iwano, K. Hirayama, Y. Kagawa, T. Ohmachi, K. Matsuda, M. Okamoto, T. Kadosawa, et al. Expression of Monocarboxylate Transporter 1 in Oral and Ocular Canine Melanocytic Tumors Vet. Pathol., July 1, 2007; 44(4): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gerweck, S. Vijayappa, and S. Kozin Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics Mol. Cancer Ther., May 1, 2006; 5(5): 1275 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Auricchio, R. Zhou, J. M. Wilson, and J. D. Glickson In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene PNAS, April 5, 2001; (2001) 81508598. [Abstract] [Full Text] |
||||
![]() |
A. Auricchio, R. Zhou, J. M. Wilson, and J. D. Glickson In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene PNAS, April 24, 2001; 98(9): 5205 - 5210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |